JP MORGAN/PUT/BECTON DICKINSON AND CO./215/0.1/17.01.25 Stock

Warrant

DE000JL1KNH0

Market Closed - Börse Stuttgart 03:11:32 2024-07-04 am EDT
1.39 EUR +0.72% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./215/0.1/17.01.25
Current month+4.51%
1 month+15.83%
Date Price Change
24-07-04 1.39 +0.72%
24-07-03 1.38 -2.13%
24-07-02 1.41 +11.90%
24-07-01 1.26 -5.26%
24-06-28 1.33 +1.53%

Delayed Quote Börse Stuttgart

Last update July 04, 2024 at 03:11 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1KNH
ISINDE000JL1KNH0
Date issued 2023-04-05
Strike 215 $
Maturity 2025-01-17 (197 Days)
Parity 10 : 1
Emission price 1.32
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.69
Lowest since issue 1.05
Spread 0.2
Spread %12.27%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
228.8 USD
Average target price
278.9 USD
Spread / Average Target
+21.86%
Consensus